The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes
Open accessAbstract
Aims/hypothesis Seroconversion to islet autoantibodies precedes type 1 diabetes. This study aimed to identify periods of high seroconversion incidence, which could be targeted for mechanistic and therapeutic studies. Methods Incidence of islet autoantibodies was calculated in 1,650 genetically at-risk children followed with measurements of islet autoantibodies and thyroid autoantibodies at age 9 months and 2, 5, 8, 11, 14 and 17 years. Peak incidence periods were confirmed in a second cohort of 150 children followed until age 6 years with three-monthly samples up to age 3 years. Results Islet autoantibody incidence (per 1,000 person-years) was 18.5 until age 9 months, 21 from 9 months to 2 years and <10 for intervals after age 2 years. The second cohort confirmed peak incidence around age 9 months and demonstrated an absence of seroconversion before this age. Seroconversion to insulin autoantibodies occurred earlier than other autoantibodies (p<0.01 against glutamic acid decarboxylase [GAD]-, insulinoma-associated protein 2 [IA-2]- and zinc transporter 8 [ZnT8]-autoantibodies). Early peak seroconversion incidence was most evident in children with high-risk HLA DR3/4-DQ8 or DR4/4-DQ8 genotypes. Conclusion The age period 9 months to 2 years is associated with a high incidence of activation of type 1 diabetes associated autoimmunity in genetically at-risk children and should be targeted for effective primary prevention strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These autoantibodies can appear as early as 6 months of age, with a peak incidence before 2 years of age in genetically susceptible individuals;66 thus, they are present months to years before symptomatic onset.”
From Type 1 diabetes (2014) · cites this paper as [66]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baekkeskov, S., Aanstoot, H.-J., Christgai, S., Reetz, A., Solimena, M., Cascalho, M., Folli, F., Richter-Olesen, H., & Camilli, P.-D. (1990) · Nature · doi:10.1038/347151a0 · Cited by 1,964
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
Atkinson, M. A., & Eisenbarth, G. S. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05415-0 · Cited by 1,491
Insulin antibodies in insulin-dependent diabetics before insulin treatment
Palmer, J. P., Asplin, C. M., Clemons, P., Lyen, K., Tatpati, O., Raghu, P. K., & Paquette, T. L. (1983) · Science · doi:10.1126/science.6362005 · Cited by 1,078
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
Wenzlau, J. M., Juhl, K., Yu, L., Moua, O., Sarkar, S. A., Gottlieb, P., Rewers, M., Eisenbarth, G. S., Jensen, J., Davidson, H. W., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705894104 · Cited by 1,014
Incidence of diabetes in youth in the United States
SEARCH for Diabetes in Youth Study Group*, T. W. G. F. T. (2007) · JAMA · doi:10.1001/jama.297.24.2716 · Cited by 991
Self-citationMaternal Alloantigens Promote the Development of Tolerogenic Fetal Regulatory T Cells in Utero
Mold, J. E., Michaëlsson, J., Burt, T. D., Muench, M. O., Beckerman, K., Busch, M. P., Lee, T., Nixon, D. F., & McCune, J. M. (2008) · Science · doi:10.1126/science.1164511 · Cited by 840
Ziegler, A., Hummel, M., Schenker, M., & Bonifacio, E. E. (1999) · Diabetes · doi:10.2337/diabetes.48.3.460 · Cited by 640
Self-citationAndersson, A., Toppari, J., Haavisto, A., Petersen, J. H., Simell, T. T., Simell, O., & Skakkebæk, N. E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4603 · Cited by 411
Kassem, S., Ariel, I., THORNTON, P. S., Scheimberg, I. B., & Gläser, B. (2000) · Diabetes · doi:10.2337/diabetes.49.8.1325 · Cited by 361
Turley, S. J., Poirot, L., Hattori, M., Benoist, C. O., & Mathis, D. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030966 · Cited by 357
Cited by
Sorted by citations
Items 201–264 of 264
L’internista ospedaliero nella gestione del paziente diabetico complesso
Magnani, G. E. L., Beltramello, G., Brancato, D., Fontanella, A., & Nardi, R. (2018) · Italian Journal of Medicine · doi:10.4081/itjm.q.2018.2 · Cited by 2
Typ-1-Diabetes im asymptomatischen Frühstadium
Achenbach, P. (2018) · Der Diabetologe · doi:10.1007/s11428-018-0341-z · Cited by 2
HLA-DQβ57, anti-insulin T cells and insulin mimicry in autoimmune diabetesPreprint
García, A. R., Paterou, A., Doherty, R. P., Landry, L., Lee, M., Anderson, A., Slawinski, H., Ferreira, R., Trzupek, D., Szypowska, A., et al. (2022) · medRxiv · doi:10.1101/2022.05.11.22274678 · Cited by 1
Mohammed, I. M., Jwaziri, A. K., & Bakr, H. M. (2024) · Academic International Journal of Medical Sciences · doi:10.59675/m221 · Cited by 1
Früherkennung des Typ-1-Diabetes im Kindesalter
Berge, T. V. D., Achenbach, P., Gemulla, G., Hummel, S., Loff, A., Kordonouri, O., & Fr1da-plex-Studiengruppe, D. (2025) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-025-02202-z · Cited by 1
Carreras, G., Mendoza, L. C., Colom, C., Tirado-Capistros, M., Sardà, H., Sánchez‐Quesada, J. L., & Pérez, A. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1699111 · Cited by 1
Wyatt, R. C., Brigatti, C., Grace, S. L., Williams, C. L., Marzinotto, I., Gillard, B. T., Bazzigaluppi, E., Shoemark, D. K., Chandler, M. A. ‐., Achenbach, P., et al. (2026) · Diabetic Medicine · doi:10.1111/dme.70277 · Cited by 1
Global determinants and preventive intervention strategies in pediatric type 1 diabetes mellitus
Soliman, N. A., Soliman, A. T., Ahmed, S., Alyafei, F., AlHumaidi, N., Hamed, N., Alaaraj, N., Yassin, D. K., & Elawwa, A. (2026) · Journal of Pediatric Endocrinology and Diabetes · doi:10.25259/jped_56_2025 · Cited by 1
Thelin, M. A., Cho, S., Callebaut, A., Nguyen, H. V., Gitelman, S. E., Kharbanda, S., Anderson, M. S., & James, E. A. (2026) · Diabetes Care · doi:10.2337/dc26-0795 · Cited by 1
Speculation on Prevention of Type 1 Diabetes
Insel, R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-4051-2_31 · Cited by 1
Insel, R. A. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0106 · Cited by 1
Diabetesformen bei Kindern und Jugendlichen
Kordonouri, O., & Raile, K. (2019) · Springer Reference Medizin · doi:10.1007/978-3-662-57309-9_12 · Cited by 1
Попова, В. В., Kp, Z., & Tronko, M. D. (2019) · PROBLEMS OF ENDOCRINE PATHOLOGY · doi:10.21856/j-pep.2019.3.18 · Cited by 1
Typ-1-Diabetes bei Kindern früh erkennen und präventiv handeln
Achenbach, P. (2022) · Diabetes aktuell · doi:10.1055/a-1839-8893 · Cited by 1
Lewis, S. J., Williams, C. L., Mortimer, G., AWAF, BOX Study Group, Oram, R. A., Hagopian, W., Gillespie, K. M., & Long, A. E. (2024) · Diabetic Medicine · doi:10.1111/dme.15394 · Cited by 1
Anti-viral action against type 1 diabetes autoimmunity: The GPPAD-AVAnT1A study protocol
Hummel, S., Käßl, A., Arnolds, S., Achenbach, P., Berner, R., Casteels, K., Hyöty, H., Kordonouri, O., Larsson, H. E., Lundgren, M., et al. (2025) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2025.101434 · Cited by 1
Self-citationKuusela, S., Keskinen, P., Pokka, T. M.-L., Knip, M., Ilonen, J., Vähäsalo, P., & Veijola, R. (2021) · Yearbook of pediatric endocrinology · doi:10.1530/ey.18.10.4 · Cited by 1
Wherrett, D. K. (2021) · Diabetes Care · doi:10.2337/dci21-0018 · Cited by 1
Roma-Wilson, M. A., & Pozzilli, P. (2026) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109230 · Cited by 1
Diagnostic d’une maladie auto-immune
Chatenoud, L. (2013) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(13)71852-5
Towards an aetiological treatment of type 1 diabetes? New tools, new strategies
Boîtard, C., & Timsit, J. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.09.001
Aspects of autoantibody epitopes in type 1 diabetes
Skärstrand, H. (2014) · Lund University Publications (Lund University)
Ilonen, J., Knip, M., & Vaarala, O. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.955474
Nieminen, J. K. (2013) · Työväentutkimus Vuosikirja
Immuno-prévention du diabète de type 1 in utero : une approche originale
Dubois‐Laforgue, D. (2016) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(16)30106-7
Étude Pre-POINT : effets immunologiques de l’insuline orale à forte dose
Dubois‐Laforgue, D. (2016) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(16)30100-6
Pathophysiologie und Prävention des Typ-1-Diabetes
Danne, T., Lange, K., & Kordonouri, O. (2016) · Springer eBooks · doi:10.1007/978-3-662-48067-0_2
Miller, R. G. (2016) · D-Scholarship@Pitt (University of Pittsburgh)
Aspects of the Pre-Diabetic Period in Type 1 Diabetes
Åkerman, L. (2016) · Linköping University medical dissertations · doi:10.3384/disss.diva-132171
Drijvers, J. M., Giani, E., Volkening, L. K., & Laffel, L. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-40242-0_10
Neue Studie zur Prävention von Typ-1-Diabetes
Ulrich, M., Winkler, C., & Ziegler, A. (2017) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0043-119618
Self-citationThe Gastrointestinal Manifestations of Type One Diabetes Mellitus in Children
Porter, J. A. (2018) · Otago University Research Archive (University of Otago)
Neue Studie zur Prävention von Typ-1-Diabetes
Winkler, C., & Ziegler, A. (2018) · Diabetes aktuell · doi:10.1055/a-0622-7805
Self-citationAlshehri, A. M., Mendis, T., & Jackson, M. W. (2018) · Journal of Immunological Methods · doi:10.1016/j.jim.2018.06.012
New approaches to induce tolerance in autoantigen-specific memory T cells in type 1 diabetes
Selck, C. (2018) · Minerva Access (University of Melbourne)
Coutant, R., Tubiana‐Rufi, N., Leroy, C., Lefebvre, C., Gueorguieva, I., Cartigny, M., Lablanche, S., & Benhamou, P. (2018) · Elsevier eBooks · doi:10.1016/b978-2-294-74942-1.00012-4
Az 1-es típusú diabetes prevenciójának jelenlegi állása
Körner, A. (2018) · Diabetologia Hungarica · doi:10.24121/dh.2018.10
Aktuelle Entwicklungen in der Prävention des Typ-1-Diabetes
Hommel, A., & Reschke, F. (2021) · Der Diabetologe · doi:10.1007/s11428-021-00759-3
Wang, B. (2021) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.174539062
The role of gluten in multiple sclerosis, psoriasis, autoimmune thyroid diseases and type 1 diabetes
Passali, M., Antvorskov, J. C., Frederiksen, J. L., & Josefsen, K. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821571-5.00003-9
Pathophysiology and Risk Factors of Diabetes
Kim, H., & Lee, B. (2021) · Stroke revisited · doi:10.1007/978-981-16-5123-6_2
Aktuelle Entwicklungen in der Prävention des Typ-1-Diabetes
Hommel, A., & Reschke, F. (2021) · Journal für Klinische Endokrinologie und Stoffwechsel · doi:10.1007/s41969-021-00152-x
Ragimov, M. R., Derevyanko, O. S., Малышева, Н. М., Zuraeva, Z. T., Nikankina, L. V., & Nikonova, T. V. (2021) · Diabetes Mellitus · doi:10.14341/dm10347
Primärprävention: Diabetes Typ 1: Wie ist der Stand der Insulinimpfung?
Ziegler, A., & Zillmer, S. (2015) · Deutsches Ärzteblatt · doi:10.3238/persdia.2015.10.23.03
Self-citationDiabetesformen bei Kindern und Jugendlichen
Kordonouri, O., & Raile, K. (2018) · Springer Reference Medizin · doi:10.1007/978-3-662-52794-8_12-1
Typ-1-Diabetes: Screening, Prävention und neue Therapien
Kick, K., Teichgräber, F. J., & Achenbach, P. (2023) · Diabetes aktuell · doi:10.1055/a-2093-9851
Früherkennung und Prävention von Typ-1-Diabetes
Ziegler, A., & Hummel, S. (2023) · Pädiatrie · doi:10.1007/s15014-023-4923-x
Self-citationSebastiani, G., Grieco, G. E., Bruttini, M., Auddino, S., Mori, A., Toniolli, M., Fignani, D., Licata, G., Nigi, L., Formichi, C., et al. (2023) · medRxiv · doi:10.1101/2023.10.08.23296650
León, J. S. T., sarmiento, L. A. D., Ayala, J. G., Hernandez, C., Rodriguez, W., Amaya, M., Estevez, M. A., Ciliberti, M., Blanco, E., Acevedo, D., et al. (2023) · doi:10.33774/coe-2023-lxq42
Teplizumab: toma de posición de la Sociedad Argentina de Diabetes
Caracotche, L., Cerrone, G. E., Dios, A. D., Frechtel, G. D., Mazza, C., Perone, M. J., Pietropaolo, G., Trabucchi, A., Trifone, L., & Valdez, S. N. (2023) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v57i3.729
The Story of Diabetes and its Causes
Malboosbaf, R., & Hatami, N. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815196535123010004
Akel, O., & Lernmark, Å. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch14
Why consider screening for preclinical stages of type 1 diabetes in children?
Berka, B., Neuman, V., Průhová, Š., & Šumnı́k, Z. (2024) · Pediatrie pro praxi · doi:10.36290/ped.2024.014
Evaluation of thyroid hormones in type 1 diabetes mellitus
Abdullah, A., & Ahmed, S. (2024) · Zanco Journal of Medical Sciences · doi:10.15218/zjms.2024.16
Envisioning Tools to Help Classify Type 1 Diabetes and Type 2 Diabetes in New-Onset Adult Diabetes
Ayers, A. T., Ho, C., Billings, L. K., Misra, S., & Klonoff, D. C. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251329055
Jönsson, J., & Lernmark, Å. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00176-9
Delaying the Onset of Type 1 Diabetes—A Review of Current Protocols and Looking at Future Options
Griffin, R., & Smith, A. (2026) · Physician Assistant Clinics · doi:10.1016/j.cpha.2025.10.003
Лаптев, Д. Н., Титович, Е. В., Федоринин, А. А., Bezlepkina, O. B., Peterkova, V. A., Рамилевич, М. И., & Mokrysheva, N. G. (2026) · Diabetes Mellitus · doi:10.14341/dm13361
Les cellules MAIT dans le diabète de type 1 chez l'homme
Nel, I. (2019) · theses.fr (ABES) · doi:10.70675/8eaa5bd8z1217z4729z8c2ezb385e0dbc1a9
Carré, A. (2022) · theses.fr (ABES) · doi:10.70675/28c85b2dz490az44c1zbbc4z061ea62b1e33
Metghalchi, S., Jones, A., Bismuth, É., Carel, J., Beltrand, J., Sola‐Gazagnes, A., Larger, É., Morel, N., Gautier, J., Riveline, J., et al. (2026) · Diabetes & Metabolism · doi:10.1016/j.diabet.2026.101797
Oxidative Stress, Post‐Translational Modifications, and Type 1 Diabetes Pathogenesis
Winstead, C. J., Hodel, M., & Tse, H. M. (2026) · Immunological Reviews · doi:10.1111/imr.70182
Metadata
- Authors
- the BABYDIAB-BABYDIET Study Group, Ziegler, A.-G., & Bonifacio, E.
- Affiliations
- Helmholtz Munich (DE)
- Corresponding author
- Ziegler, A.-G.
- Venue
- Diabetologia
- Published
- 2012-01-31
- Volume
- 55
- Issue
- 7
- Pages
- 1937-1943
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2030685032
- Cited by
- 264
- References
- 30
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 21 · 2023: 24 · 2022: 14 · 2021: 18 · 2020: 10 · 2019: 14 · 2018: 27 · 2017: 13 · 2016: 32 · 2015: 27 · 2014: 15 · 2013: 18 · 2012: 5
- FWCI
- 12.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- Funders
- European Commission (202013)
- Deutsche Forschungsgemeinschaft (FZ 111, /14-1)
- Bundesministerium für Bildung und Forschung (FKZ 01GI0805‐07, FKZ 01GI0805, 01GI0805, 01GI0805-07)
- Helmholtz Zentrum München
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 1 diabetes, islet autoantibodies, seroconversion, insulin autoantibodies, glutamic acid decarboxylase antibodies, IA-2 autoantibodies, ZnT8 autoantibodies, thyroid autoantibodies, primary prevention
- MeSH terms
- Adolescent, Autoantibodies, Child, Child, Preschool, Diabetes Mellitus, Type 1, Female, Genotype, Germany, HLA-D Antigens, Humans, Infant, Longitudinal Studies, Male, Prediabetic State, Cohort Studies, Incidence, Polymerase Chain Reaction, Child of Impaired Parents, Age of Onset, Disease Progression, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review